Our results also demonstrate that quiescent CD44 on normal cells could be activated in tumor microenvironments (Fig. S1 in S1 Supplemental Data), providing additional evidence for the specific active state of CD44 on tumor cells. The gene discussed is CD44; the disease is neoplasm.